Abstract
Background:Rheumatology has entered the era of biosimilar drugs. Compared with the original approved biological drug, a biosimilar has highly similar physiochemical characteristics and biological activity1. There is also equivalent efficacy...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
